Oral disease modifying drugs and adherence

Three studies were reported at the recent CMSC meeting in Indianapolis. One study found that more people on an oral disease modifying drug missed a dose than for people on an injectable. A second study found similar adherence rates between the two types of administration and that about a quarter of both groups stopped taking their treatment. The third study compared adherence rates for the three oral disease modifying drugs. MedPage Today Disease modifying drugs for relapsing MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news